Insider · CIK 0002150331
Jarrad Mattieu Aguirre
Files at LYEL (Lyell Immunopharma, Inc.). First filing -, latest -.
Jarrad Mattieu Aguirre files SEC Form 4 as officer at LYEL (Lyell Immunopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jarrad Mattieu Aguirre has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | LYEL Lyell Immunopharma, Inc. | AGrant or award Option (right to buy)derivative | +47,500 | $0.00 | $0 | 47,500 | 33 d ago |
Questions about Jarrad Mattieu Aguirre
Answered from the filings on this page, as of the latest one.
Is Jarrad Mattieu Aguirre buying or selling?
Jarrad Mattieu Aguirre has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jarrad Mattieu Aguirre's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jarrad Mattieu Aguirre has 0.
Where does Jarrad Mattieu Aguirre file Form 4?
Jarrad Mattieu Aguirre has filed Form 4 at LYEL (Lyell Immunopharma, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.